# FDA Inspection 1162932 - Robert J. Kreitman, MD - February 03, 2022

Source: https://www.keypedia.com/records/fda_inspections/robert-j-kreitman-md/b3bea8ca-7416-4e3e-91a3-e82463a6eee9
Source feed: FDA_Inspections

> FDA Inspection 1162932 for Robert J. Kreitman, MD on February 03, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162932
- Company Name: Robert J. Kreitman, MD
- Inspection Date: 2022-02-03
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 940561 - 2015-08-28](https://www.keypedia.com/records/fda_inspections/robert-j-kreitman-md/e2501174-117d-4b89-96c0-cbf5ad6dd7a9)

Company: https://www.keypedia.com/companies/robert-j-kreitman-md/8b63b1db-e0fe-4487-b8f8-6bf5a412e8e4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c